Natural killer cell responses during viral infections: Flexibility and conditioning of innate immunity by experience

Current Opinion in Virology

Volumn 1, Issue 6, 2011, Pages 497-512

  Vidal, Silvia M ^a   Khakoo, Salim I ^b   Biron, Christine A ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; STAT1 PROTEIN; STAT2 PROTEIN; STAT4 PROTEIN;

ADAPTIVE IMMUNITY; ARTICLE; CELL PROLIFERATION; CELL SUBPOPULATION; CYTOMEGALOVIRUS; EBOLA VIRUS; EPSTEIN BARR VIRUS; HANTAVIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNOREGULATION; INFLUENZA VIRUS; INNATE IMMUNITY; MARBURG VIRUS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; VACCINIA VIRUS; VIRUS INFECTION;

EID: 82955182165     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2011.10.017     Document Type: Review

References (125)

1. G. Trinchieri Biology of natural killer cells Adv Immunol 47 1989 187 376 (Pubitemid 20010960)
2. E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini Functions of natural killer cells Nat Immunol 9 2008 503 510 (Pubitemid 351560519)
3. C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu Rev Immunol 17 1999 189 220 (Pubitemid 29241123)
4. J.S. Orange, and Z.K. Ballas Natural killer cells in human health and disease Clin Immunol 118 2006 1 10 (Pubitemid 43012040)
5. S.H. Lee, and C.A. Biron Here today - not gone tomorrow: roles for activating receptors in sustaining NK cells during viral infections Eur J Immunol 40 2010 923 932
6. S.H. Lee, T. Miyagi, and C.A. Biron Keeping NK cells in highly regulated antiviral warfare Trends Immunol 28 2007 252 259 (Pubitemid 46810349)
7. C.L. Sentman, M.Y. Olsson, and K. Karre Missing self recognition by natural killer cells in MHC class I transgenic mice. A 'receptor calibration' model for how effector cells adapt to self Semin Immunol 7 1995 109 119
8. L.L. Lanier Up on the tightrope: natural killer cell activation and inhibition Nat Immunol 9 2008 495 502 (Pubitemid 351560518)
9. L.L. Lanier NK cell recognition Annu Rev Immunol 23 2005 225 274 (Pubitemid 40563170)
10. K. Natarajan, N. Dimasi, J. Wang, R.A. Mariuzza, and D.H. Margulies Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination Annu Rev Immunol 20 2002 853 885 (Pubitemid 34293442)
11. W.M. Yokoyama, and B.F. Plougastel Immune functions encoded by the natural killer gene complex Nat Rev Immunol 3 2003 304 316 (Pubitemid 37328683)
12. P. Parham MHC class I molecules and KIRs in human history, health and survival Nat Rev Immunol 5 2005 201 214 (Pubitemid 40364822)
13. J.R. Carlyle, A. Mesci, J.H. Fine, P. Chen, S. Belanger, L.H. Tai, and A.P. Makrigiannis Evolution of the Ly49 and Nkrp1 recognition systems Semin Immunol 20 2008 321 330
14. S. Bahram, H. Inoko, T. Shiina, and M. Radosavljevic MIC and other NKG2D ligands: from none to too many Curr Opin Immunol 17 2005 505 509 (Pubitemid 41207954)
15. R.E. Vance, A.M. Jamieson, and D.H. Raulet Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells J Exp Med 190 1999 1801 1812 (Pubitemid 30013846)
16. F. Borrego, M. Masilamani, A.I. Marusina, X. Tang, and J.E. Coligan The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance Immunol Res 35 2006 263 278
17. A.W.t. MacFarlane, and K.S. Campbell Signal transduction in natural killer cells Curr Top Microbiol Immunol 298 2006 23 57
18. L.L. Lanier DAP10- and DAP12-associated receptors in innate immunity Immunol Rev 227 2009 150 160
19. A. Kikuchi-Maki, T.L. Catina, and K.S. Campbell Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein J Immunol 174 2005 3859 3863 (Pubitemid 40395957)
20. A.A. Scalzo, N.A. Fitzgerald, A. Simmons, A.B. La Vista, and G.R. Shellam Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen J Exp Med 171 1990 1469 1483 (Pubitemid 20167544)
21. S.H. Lee, S. Girard, D. Macina, M. Busa, A. Zafer, A. Belouchi, P. Gros, and S.M. Vidal Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily Nat Genet 28 2001 42 45 (Pubitemid 32405814)
22. M.G. Brown, A.O. Dokun, J.W. Heusel, H.R. Smith, D.L. Beckman, E.A. Blattenberger, C.E. Dubbelde, L.R. Stone, A.A. Scalzo, and W.M. Yokoyama Vital involvement of a natural killer cell activation receptor in resistance to viral infection Science 292 2001 934 937 (Pubitemid 32422491)
23. H. Arase, E.S. Mocarski, A.E. Campbell, A.B. Hill, and L.L. Lanier Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors Science 296 2002 1323 1326 (Pubitemid 34522789)
24. H.R. Smith, J.W. Heusel, I.K. Mehta, S. Kim, B.G. Dorner, O.V. Naidenko, K. Iizuka, H. Furukawa, D.L. Beckman, and J.T. Pingel Recognition of a virus-encoded ligand by a natural killer cell activation receptor Proc Natl Acad Sci USA 99 2002 8826 8831 (Pubitemid 34693643)
25. A.O. Dokun, S. Kim, H.R. Smith, H.S. Kang, D.T. Chu, and W.M. Yokoyama Specific and nonspecific NK cell activation during virus infection Nat Immunol 2 2001 951 956 (Pubitemid 32976168)
26. R. Gazit, R. Gruda, M. Elboim, T.I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, and E. Greenbaum Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1 Nat Immunol 7 2006 517 523
27. M.P. Desrosiers, A. Kielczewska, J.C. Loredo-Osti, S.G. Adam, A.P. Makrigiannis, S. Lemieux, T. Pham, M.B. Lodoen, K. Morgan, and L.L. Lanier Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection Nat Genet 37 2005 593 599 (Pubitemid 40774887)
28. A. Dighe, M. Rodriguez, P. Sabastian, X. Xie, M. McVoy, and M.G. Brown Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice J Immunol 175 2005 6820 6828 (Pubitemid 41598926)
29. A. Kielczewska, M. Pyzik, T. Sun, A. Krmpotic, M.B. Lodoen, M.W. Munks, M. Babic, A.B. Hill, U.H. Koszinowski, and S. Jonjic Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response J Exp Med 206 2009 515 523
30. X. Xie, M.D. Stadnisky, E.R. Coats, M.M. Ahmed Rahim, A. Lundgren, W. Xu, A.P. Makrigiannis, and M.G. Brown MHC class I D(k) expression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirus Proc Natl Acad Sci USA 107 2010 8754 8759
31. N. Fodil-Cornu, J.C. Loredo-Osti, and S.M. Vidal NK cell receptor/H2-Dk-dependent host resistance to viral infection is quantitatively modulated by H2q inhibitory signals PLoS Genet 7 2011 e1001368
32. M. Pyzik, B. Charbonneau, E.M. Gendron-Pontbriand, M. Babic, A. Krmpotic, S. Jonjic, and S.M. Vidal Distinct MHC class I-dependent NK cell-activating receptors control cytomegalovirus infection in different mouse strains J Exp Med 208 2011 1105 1117
33. M. Fang, M.T. Orr, P. Spee, T. Egebjerg, L.L. Lanier, and L.J. Sigal CD94 is essential for NK cell-mediated resistance to a lethal viral disease Immunity 34 2011 579 589
34. M. Champsaur, and L.L. Lanier Effect of NKG2D ligand expression on host immune responses Immunol Rev 235 2010 267 285
35. V.J. Lisnic, A. Krmpotic, and S. Jonjic Modulation of natural killer cell activity by viruses Curr Opin Microbiol 13 2010 530 539
36. M. Babic, M. Pyzik, B. Zafirova, M. Mitrovic, V. Butorac, L.L. Lanier, A. Krmpotic, S.M. Vidal, and S. Jonjic Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo J Exp Med 207 2010 2663 2673
37. M.T. Orr, W.J. Murphy, and L.L. Lanier 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection Nat Immunol 11 2010 321 327
38. X. Xie, M.D. Stadnisky, and M.G. Brown MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus J Immunol 182 2009 7163 7171
39. I. Barao, M. Alvarez, E. Ames, M.T. Orr, H.E. Stefanski, B.R. Blazar, L.L. Lanier, S.K. Anderson, D. Redelman, and W.J. Murphy Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC Blood 117 2011 7032 7041
40. X. Guo, Y. Chen, X. Li, H. Kong, S. Yang, B. Ye, D. Cui, W. Wu, and L. Li Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection Virol J 8 2011 215
41. B. Amadei, S. Urbani, A. Cazaly, P. Fisicaro, A. Zerbini, P. Ahmed, G. Missale, C. Ferrari, and S.I. Khakoo Activation of natural killer cells during acute infection with hepatitis C virus Gastroenterology 138 2010 1536 1545
42. N.K. Bjorkstrom, T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaelsson, K.J. Malmberg, J. Klingstrom, and C. Ahlm Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus J Exp Med 208 2011 13 21
43. M. Guma, A. Angulo, C. Vilches, N. Gomez-Lozano, N. Malats, and M. Lopez-Botet Imprint of human cytomegalovirus infection on the NK cell receptor repertoire Blood 104 2004 3664 3671 (Pubitemid 39564443)
44. P. Tomasec, V.M. Braud, C. Rickards, M.B. Powell, B.P. McSharry, S. Gadola, V. Cerundolo, L.K. Borysiewicz, A.J. McMichael, and G.W. Wilkinson Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40 Science 287 2000 1031
45. B. Oliviero, S. Varchetta, E. Paudice, G. Michelone, M. Zaramella, D. Mavilio, F. De Filippi, S. Bruno, and M.U. Mondelli Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology 137 2009 1151 1160 1160 e1151-1157
46. G. Ahlenstiel, R.H. Titerence, C. Koh, B. Edlich, J.J. Feld, Y. Rotman, M.G. Ghany, J.H. Hoofnagle, T.J. Liang, and T. Heller Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa- dependent manner Gastroenterology 138 2010 325 335 e321-322
47. S. Boulet, S. Sharafi, N. Simic, J. Bruneau, J.P. Routy, C.M. Tsoukas, and N.F. Bernard Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals AIDS 22 2008 595 599 (Pubitemid 351640592)
48. M.P. Martin, X. Gao, J.H. Lee, G.W. Nelson, R. Detels, J.J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, and J. Trowsdale Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS Nat Genet 31 2002 429 434 (Pubitemid 35154456)
49. Y. Qi, M.P. Martin, X. Gao, L. Jacobson, J.J. Goedert, S. Buchbinder, G.D. Kirk, S.J. O'Brien, J. Trowsdale, and M. Carrington KIR/HLA pleiotropism: protection against both HIV and opportunistic infections PLoS Pathog 2 2006 e79
50. G. Alter, M.P. Martin, N. Teigen, W.H. Carr, T.J. Suscovich, A. Schneidewind, H. Streeck, M. Waring, A. Meier, and C. Brander Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes J Exp Med 204 2007 3027 3036 (Pubitemid 350179568)
51. T.I. Arnon, M. Lev, G. Katz, Y. Chernobrov, A. Porgador, and O. Mandelboim Recognition of viral hemagglutinins by NKp44 but not by NKp30 Eur J Immunol 31 2001 2680 2689 (Pubitemid 32898735)
52. O. Mandelboim, N. Lieberman, M. Lev, L. Paul, T.I. Arnon, Y. Bushkin, D.M. Davis, J.L. Strominger, J.W. Yewdell, and A. Porgador Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells Nature 409 2001 1055 1060 (Pubitemid 32204059)
53. C.L. Fuller, G. Ruthel, K.L. Warfield, D.L. Swenson, C.M. Bosio, M.J. Aman, and S. Bavari NKp30-dependent cytolysis of filovirus-infected human dendritic cells Cell Microbiol 9 2007 962 976 (Pubitemid 46394907)
54. S.E. Chisholm, K. Howard, M.V. Gomez, and H.T. Reyburn Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors J Infect Dis 195 2007 1160 1168 (Pubitemid 46543447)
55. C.A. Stewart, F. Laugier-Anfossi, F. Vely, X. Saulquin, J. Riedmuller, A. Tisserant, L. Gauthier, F. Romagne, G. Ferracci, and F.A. Arosa Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors Proc Natl Acad Sci USA 102 2005 13224 13229 (Pubitemid 41325005)
56. S.E. Chisholm, and H.T. Reyburn Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors J Virol 80 2006 2225 2233 (Pubitemid 43271529)
57. M. Thomas, J.M. Boname, S. Field, S. Nejentsev, M. Salio, V. Cerundolo, M. Wills, and P.J. Lehner Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity Proc Natl Acad Sci USA 105 2008 1656 1661 (Pubitemid 351346570)
58. M. Llano, M. Guma, M. Ortega, A. Angulo, and M. Lopez-Botet Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets Eur J Immunol 33 2003 2744 2754 (Pubitemid 37337140)
59. C.R. Brooks, T. Elliott, P. Parham, and S.I. Khakoo The inhibitory receptor NKG2A determines lysis of vaccinia virus-infected autologous targets by NK cells J Immunol 176 2006 1141 1147 (Pubitemid 43099716)
60. S. Boulet, R. Song, P. Kamya, J. Bruneau, N.H. Shoukry, C.M. Tsoukas, and N.F. Bernard HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells J Immunol 184 2010 2057 2064
61. M.P. Martin, Y. Qi, X. Gao, E. Yamada, J.N. Martin, F. Pereyra, S. Colombo, E.E. Brown, W.L. Shupert, and J. Phair Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 Nat Genet 39 2007 733 740 (Pubitemid 46848586)
62. S.I. Khakoo, C.L. Thio, M.P. Martin, C.R. Brooks, X. Gao, J. Astemborski, J. Cheng, J.J. Goedert, D. Vlahov, and M. Hilgartner HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection Science 305 2004 872 874 (Pubitemid 39038423)
63. S. Knapp, U. Warshow, D. Hegazy, L. Brackenbury, I.N. Guha, A. Fowell, A.M. Little, G.J. Alexander, W.M. Rosenberg, and M.E. Cramp Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus Hepatology 51 2010 1168 1175
64. V. Romero, J. Azocar, J. Zuniga, O.P. Clavijo, D. Terreros, X. Gu, Z. Husain, R.T. Chung, C. Amos, and E.J. Yunis Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome Mol Immunol 45 2008 2429 2436
65. J.R. Vidal-Castineira, A. Lopez-Vazquez, R. Diaz-Pena, R. Alonso-Arias, J. Martinez-Borra, R. Perez, J. Fernandez-Suarez, S. Melon, J. Prieto, and L. Rodrigo Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection J Virol 84 2010 475 481
66. L. Fadda, G. Borhis, P. Ahmed, K. Cheent, S.V. Pageon, A. Cazaly, S. Stathopoulos, D. Middleton, A. Mulder, and F.H. Claas Peptide antagonism as a mechanism for NK cell activation Proc Natl Acad Sci USA 107 2010 10160 10165
67. B.P. Dolan, J.R. Bennink, and J.W. Yewdell Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands Cell Mol Life Sci 68 2011 1481 1489
68. L. Fadda, G.M. O'Connor, S. Kumar, A. Piechocka-Trocha, C.M. Gardiner, M. Carrington, D.W. McVicar, and M. Altfeld Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules J Virol 85 2011 5970 5974
69. G. Alter, D. Heckerman, A. Schneidewind, L. Fadda, C.M. Kadie, J.M. Carlson, C. Oniangue-Ndza, M. Martin, B. Li, and S.I. Khakoo HIV-1 adaptation to NK-cell-mediated immune pressure Nature 476 2011 96 100
70. Y.T. Bryceson, H.G. Ljunggren, and E.O. Long Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors Blood 114 2009 2657 2666
71. T. Horng, J.S. Bezbradica, and R. Medzhitov NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway Nat Immunol 8 2007 1345 1352 (Pubitemid 350138973)
72. C.A. Biron, and G. Sen Innate immune responses to viral infection D.M. Knipe, P.M. Howley, Fields Virology 2007 Walter Kluwer/Lippincott, Williams & Williams 249 278
73. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, T.J. Urban, E.L. Heinzen, P. Qiu, A.H. Bertelsen, and A.J. Muir Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
74. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, M.L. Abate, M. Bassendine, U. Spengler, G.J. Dore, and E. Powell IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 2009 1100 1104
75. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, N. Sakamoto, M. Nakagawa, M. Korenaga, K. Hino, and S. Hige Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 2009 1105 1109
76. D.L. Thomas, C.L. Thio, M.P. Martin, Y. Qi, D. Ge, C. O'Huigin, J. Kidd, K. Kidd, S.I. Khakoo, and G. Alexander Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
77. A. Rauch, Z. Kutalik, P. Descombes, T. Cai, J. Di Iulio, T. Mueller, M. Bochud, M. Battegay, E. Bernasconi, and J. Borovicka Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345 1345 e1331-1337
78. M.M. Dring, M.H. Morrison, B.P. McSharry, K.J. Guinan, R. Hagan, C. O'Farrelly, and C.M. Gardiner Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection Proc Natl Acad Sci USA 108 2011 5736 5741
79. S. Knapp, U. Warshow, K.M. Ho, D. Hegazy, A.M. Little, A. Fowell, G. Alexander, M. Thursz, M. Cramp, and S.I. Khakoo A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection Gastroenterology 141 2011 320 325
80. T.J. Urban, A.J. Thompson, S.S. Bradrick, J. Fellay, D. Schuppan, K.D. Cronin, L. Hong, A. McKenzie, K. Patel, and K.V. Shianna IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C Hepatology 52 2010 1888 1896
81. C.M. Lange, D. Moradpour, A. Doehring, H.A. Lehr, B. Mullhaupt, S. Bibert, P.Y. Bochud, A.T. Antonino, M. Pascual, and H. Farnik Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection J Hepatol 55 2011 322 327
82. H. Williams, K. McAulay, K.F. Macsween, N.J. Gallacher, C.D. Higgins, N. Harrison, A.J. Swerdlow, and D.H. Crawford The immune response to primary EBV infection: a role for natural killer cells Br J Haematol 129 2005 266 274 (Pubitemid 40562448)
83. U.C. Meier, R.E. Owen, E. Taylor, A. Worth, N. Naoumov, C. Willberg, K. Tang, P. Newton, P. Pellegrino, and I. Williams Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections J Virol 79 2005 12365 12374 (Pubitemid 41346098)
84. H.S. Hong, J.M. Eberhard, P. Keudel, B.A. Bollmann, M. Ballmaier, N. Bhatnagar, M. Zielinska-Skowronek, R.E. Schmidt, and D. Meyer-Olson HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells J Virol 84 2010 1183 1188
85. C. Morishima, D.M. Paschal, C.C. Wang, C.S. Yoshihara, B.L. Wood, A.E. Yeo, S.S. Emerson, M.C. Shuhart, and D.R. Gretch Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing Hepatology 43 2006 573 580
86. L. Golden-Mason, L. Madrigal-Estebas, E. McGrath, M.J. Conroy, E.J. Ryan, J.E. Hegarty, C. O'Farrelly, and D.G. Doherty Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure Gut 57 2008 1121 1128
87. R. Tarazona, J.G. Casado, O. Delarosa, J. Torre-Cisneros, J.L. Villanueva, B. Sanchez, M.D. Galiani, R. Gonzalez, R. Solana, and J. Pena Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals J Clin Immunol 22 2002 176 183 (Pubitemid 34596941)
88. G. Alter, S. Rihn, K. Walter, A. Nolting, M. Martin, E.S. Rosenberg, J.S. Miller, M. Carrington, and M. Altfeld HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection J Virol 83 2009 6798 6805
89. S.H. Lee, K.S. Kim, N. Fodil-Cornu, S.M. Vidal, and C.A. Biron Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection J Exp Med 206 2009 2235 2251
90. A. Crawford, and E.J. Wherry The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses Curr Opin Immunol 21 2009 179 186
91. S. Pelletier, C. Drouin, N. Bedard, S.I. Khakoo, J. Bruneau, and N.H. Shoukry Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses J Hepatol 53 2010 805 816
92. A. De Maria, M. Fogli, S. Mazza, M. Basso, A. Picciotto, P. Costa, S. Congia, M.C. Mingari, and L. Moretta Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients Eur J Immunol 37 2007 445 455 (Pubitemid 46915584)
93. J.C. Sun, J.N. Beilke, and L.L. Lanier Adaptive immune features of natural killer cells Nature 457 2009 557 561
94. S. Paust, H.S. Gill, B.Z. Wang, M.P. Flynn, E.A. Moseman, B. Senman, M. Szczepanik, A. Telenti, P.W. Askenase, and R.W. Compans Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses Nat Immunol 11 2010 1127 1135
95. J.C. Sun, J.N. Beilke, N.A. Bezman, and L.L. Lanier Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection J Exp Med 208 2011 357 368
96. C.A. Biron More things in heaven and earth: defining innate and adaptive immunity Nat Immunol 11 2010 1080 1082
97. C.A. Biron, M. Dalod, and T.P. Salazar-Mather Innate immunity and viral infections S.H.E. Kaufman, A. Sherr, R. Ahmed, Immunology of Infectious Diseases 2002 American Society for Microbiology 139 160
98. J.S. Orange, and C.A. Biron An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections J Immunol 156 1996 1138 1142
99. K.B. Nguyen, T.P. Salazar-Mather, M.Y. Dalod, J.B. Van Deusen, X.Q. Wei, F.Y. Liew, M.A. Caligiuri, J.E. Durbin, and C.A. Biron Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection J Immunol 169 2002 4279 4287 (Pubitemid 35178200)
100. G.C. Pien, A.R. Satoskar, K. Takeda, S. Akira, and C.A. Biron Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection J Immunol 165 2000 4787 4791
101. C. Asselin-Paturel, A. Boonstra, M. Dalod, I. Durand, N. Yessaad, C. Dezutter-Dambuyant, A. Vicari, A. O'Garra, C. Biron, and F. Briere Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology Nat Immunol 2 2001 1144 1150 (Pubitemid 33130149)
102. T. Delale, A. Paquin, C. Asselin-Paturel, M. Dalod, G. Brizard, E.E. Bates, P. Kastner, S. Chan, S. Akira, and A. Vicari MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo J Immunol 175 2005 6723 6732 (Pubitemid 41598916)
103. A. Krug, A.R. French, W. Barchet, J.A. Fischer, A. Dzionek, J.T. Pingel, M.M. Orihuela, S. Akira, W.M. Yokoyama, and M. Colonna TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function Immunity 21 2004 107 119 (Pubitemid 38925271)
104. V.A. Rathinam, Z. Jiang, S.N. Waggoner, S. Sharma, L.E. Cole, L. Waggoner, S.K. Vanaja, B.G. Monks, S. Ganesan, and E. Latz The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses Nat Immunol 11 2010 395 402
105. G.C. Pien, K.B. Nguyen, L. Malmgaard, A.R. Satoskar, and C.A. Biron A unique mechanism for innate cytokine promotion of T cell responses to viral infections J Immunol 169 2002 5827 5837 (Pubitemid 35291686)
106. J. Louten, N. van Rooijen, and C.A. Biron Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection J Immunol 177 2006 3266 3272 (Pubitemid 44277846)
107. T. Miyagi, M.P. Gil, X. Wang, J. Louten, W.M. Chu, and C.A. Biron High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells J Exp Med 204 2007 2383 2396 (Pubitemid 47529324)
108. A.R. Stacey, P.J. Norris, L. Qin, E.A. Haygreen, E. Taylor, J. Heitman, M. Lebedeva, A. DeCamp, D. Li, and D. Grove Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections J Virol 83 2009 3719 3733
109. C. Dunn, D. Peppa, P. Khanna, G. Nebbia, M. Jones, N. Brendish, R.M. Lascar, D. Brown, R.J. Gilson, and R.J. Tedder Temporal analysis of early immune responses in patients with acute hepatitis B virus infection Gastroenterology 137 2009 1289 1300
110. S. Wieland, R. Thimme, R.H. Purcell, and F.V. Chisari Genomic analysis of the host response to hepatitis B virus infection Proc Natl Acad Sci USA 101 2004 6669 6674 (Pubitemid 38586032)
111. S. Wieland, and F.V. Chisari Stealth and cunning: hepatitis B and hepatitis C viruses J Virol 79 2005 9369 9380 (Pubitemid 41022281)
112. R.E. Lanford, Z. Feng, D. Chavez, B. Guerra, K.M. Brasky, Y. Zhou, D. Yamane, A.S. Perelson, C.M. Walker, and S.M. Lemon Acute hepatitis A virus infection is associated with a limited type 1 interferon response and persistence of intrahepatic viral RNA Proc Natl Acad Sci USA 108 2011 11223 11228
113. A. Garcia-Sastre, and C.A. Biron Type 1 interferons and the virus-host relationship: a lesson in detente Science 312 2006 879 882 (Pubitemid 43727313)
114. Y. Rochman, R. Spolski, and W.J. Leonard New insights into the regulation of T cells by gamma(c) family cytokines Nat Rev Immunol 9 2009 480 490
115. S.D. Der, A. Zhou, B.R. Williams, and R.H. Silverman Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays Proc Natl Acad Sci USA 95 1998 15623 15628 (Pubitemid 29018750)
116. L.H. Wong, H. Sim, M. Chatterjee-Kishore, I. Hatzinisiriou, R.J. Devenish, G. Stark, and S.J. Ralph Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1 J Biol Chem 277 2002 19408 19417 (Pubitemid 34967449)
117. J.F. Bromberg, C.M. Horvath, Z. Wen, R.D. Schreiber, and J.E. Darnell Jr. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma Proc Natl Acad Sci USA 93 1996 7673 7678 (Pubitemid 26277095)
118. M.P. Gil, R. Salomon, J. Louten, and C.A. Biron Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo Blood 107 2006 987 993 (Pubitemid 43156296)
119. J.S. Orange, and C.A. Biron Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection J Immunol 156 1996 4746 4756 (Pubitemid 26174459)
120. A.R. French, H. Sjolin, S. Kim, R. Koka, L. Yang, D.A. Young, C. Cerboni, E. Tomasello, A. Ma, and E. Vivier DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections J Immunol 177 2006 4981 4990 (Pubitemid 44527567)
121. J.C. Sun, A. Ma, and L.L. Lanier Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection J Immunol 183 2009 2911 2914
122. T. Miyagi, T. Takehara, K. Nishio, S. Shimizu, K. Kohga, W. Li, T. Tatsumi, N. Hiramatsu, T. Kanto, and N. Hayashi Altered interferon-alpha- signaling in natural killer cells from patients with chronic hepatitis C virus infection J Hepatol 53 2010 424 430
123. E.A. Mack, L.E. Kallal, D.A. Demers, and C.A. Biron Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection MBio 2 2011 e00169 e211
124. S.S. Farag, J.B. VanDeusen, T.A. Fehniger, and M.A. Caligiuri Biology and clinical impact of human natural killer cells Int J Hematol 78 2003 7 17 (Pubitemid 36899896)
125. Y. Hayakawa, N.D. Huntington, S.L. Nutt, and M.J. Smyth Functional subsets of mouse natural killer cells Immunol Rev 214 2006 47 55 (Pubitemid 44707901)